4880 Ilepatril Ilepatril is a dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, for the treatment of hypertension and diabetic nephropathy. 473289-62-2 C22H28N2O5S White powder. No indication of carcinogenicity to humans (not listed by IARC). 2014-09-11T05:18:08Z 2026-04-04T01:56:27Z DB06604 true [H][C@]12CCC[C@H](N1C(=O)[C@H](CC1=C2C=CC=C1)NC(=O)[C@@H](SC(C)=O)C(C)C)C(O)=O C22H28N2O5S InChI=1S/C22H28N2O5S/c1-12(2)19(30-13(3)25)20(26)23-16-11-14-7-4-5-8-15(14)17-9-6-10-18(22(28)29)24(17)21(16)27/h4-5,7-8,12,16-19H,6,9-11H2,1-3H3,(H,23,26)(H,28,29)/t16-,17+,18-,19-/m0/s1 FXKFFTMLFPWYFH-RDGPPVDQSA-N 432.533 432.171892706 Exogenous Solid CHEM003781 DTXSID7047356 NS00031679 (2R,6S,9S)-9-[(2S)-2-(acetylsulfanyl)-3-methylbutanamido]-8-oxo-7-azatricyclo[9.4.0.0²,⁷]pentadeca-1(11),12,14-triene-6-carboxylic acid